Holding(s) in Company
April 16 2010 - 10:46AM
UK Regulatory
TIDMNPH TIDMLLOY
RNS Number : 3454K
Neuropharm Group PLC
16 April 2010
+------------------------------+------------------------------------+
| For immediate release | 16 April 2010 |
+------------------------------+------------------------------------+
Neuropharm Group plc
("Neuropharm" or the "Company")
TR-1: Notification of Major Interests in Shares
+-----------------------------------------+-------------------------+
| 1. Identity of the issuer or the | Neuropharm Group plc |
| underlying issuer of existing shares to | |
| which voting rights are attached: | |
+-----------------------------------------+-------------------------+
| 2. Reason for the notification | |
+-----------------------------------------+-------------------------+
| An acquisition or disposal of voting | Yes |
| rights | |
+-----------------------------------------+-------------------------+
| 3. Full name of person(s) subject to | Lloyds Banking Group |
| the notification obligation: | plc |
+-----------------------------------------+-------------------------+
| 4. Full name of shareholder(s) (if | See Section 9. |
| different from 3.): | |
+-----------------------------------------+-------------------------+
| 5. Date of the transaction and date on | 14 April 2010 |
| which the threshold is crossed or | |
| reached: | |
+-----------------------------------------+-------------------------+
| 6. Date on which issuer notified: | 15 April 2010 |
+-----------------------------------------+-------------------------+
| 7. Threshold(s) that is/are crossed or | Direct/indirect |
| reached: | holdings decreased to |
| | below 9% |
+-----------------------------------------+-------------------------+
+--------------+------------+-----------+-----------+------------+-----------+----------+------------+----------+
| 8. Notified details: | | |
+----------------------------------------------------------------+-----------------------------------+----------+
| A: Voting rights attached to shares |
+---------------------------------------------------------------------------------------------------------------+
| Class/type | Situation | Resulting situation after the triggering transaction |
| of shares | previous to the | |
| if | Triggering | |
| possible | transaction | |
| using the | | |
| ISIN CODE | | |
+ +------------------------+-----------------------------------------------------------------------+
| | Number of | Number | Number | Number of | % of voting rights |
| | Shares | of | of | voting rights | |
| | | Voting | shares | | |
| | | Rights | Direct | | |
+ + + + +------------------------+----------------------------------+
| | | | | Direct | Indirect | Direct | Indirect |
+--------------+------------+-----------+-----------+------------+-----------+----------+-----------------------+
| Ord 10p | 3,036,616 |3,036,616 |1,320,452 | 1,320,452 |1,499,622 | 4.187% | 4.755% |
| Shares | | | | | | | |
+--------------+ + + + + + + +
|GB00B1NPJJ01 | | | | | | | |
+--------------+------------+-----------+-----------+------------+-----------+----------+-----------------------+
| | | | | | | | | |
+--------------+------------+-----------+-----------+------------+-----------+----------+------------+----------+
+-------------+------------+---------------+----------------+---------+
| B: Financial Instruments |
+---------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+---------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | Number of | % of |
| financial | date | Conversion | voting rights | voting |
| instrument | | Period/ Date | that may be | rights |
| | | | acquired if | |
| | | | the instrument | |
| | | | is exercised/ | |
| | | | converted | |
+-------------+------------+---------------+----------------+---------+
| | | | | |
+-------------+------------+---------------+----------------+---------+
+--------------+----------+------------+-----------------+-------------+
| C: Financial Instruments with similar economic effect to |
| Qualifying Financial Instruments |
+----------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+----------------------------------------------------------------------+
| Type of | Exercise | Expiration | Number of | % of voting |
| financial | price | date | voting rights | rights |
| instrument | | | instrument | |
| | | | refers to | |
| | | | | |
+--------------+----------+------------+-----------------+-------------+
| | | | | |
+--------------+----------+------------+-----------------+-------------+
+--------------------------------+----------------------------------+
| Total (A+B+C) |
+-------------------------------------------------------------------+
| Number of voting rights | % of voting rights |
+--------------------------------+----------------------------------+
| 2,820,074 | 8.942% |
+--------------------------------+----------------------------------+
+-------------------------------------------------------------------+
| 9. Chain of controlled undertakings through which the voting |
| rights and/or the financial instruments are effectively held, if |
| applicable: |
+-------------------------------------------------------------------+
| 2,820,062 shares (8.942%) are under the control of Scottish |
| Widows Investment Partnership Ltd, a wholly owned subsidiary of |
| Scottish Widows Group Ltd, a wholly owned subsidiary of Lloyds |
| TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group |
| plc (Direct/Indirect Interests). |
| Within these holdings, 1,305,727 shares (4.140%) are managed on |
| behalf of Clerical Medical Investment Group Limited, a wholly |
| owned subsidiary of HBOS Financial Services Limited, a wholly |
| owned subsidiary of HBOS Insurance & Investment Group Limited, a |
| wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of |
| Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking |
| Group plc, These holdings are therefore disclosed as an overall |
| Direct Interest. |
+-------------------------------------------------------------------+
+------------------------------------------+------------------------+
| Proxy Voting: |
+-------------------------------------------------------------------+
| 10. Name of the proxy holder: | N/A |
+------------------------------------------+------------------------+
| 11. Number of voting rights proxy holder | N/A |
| will cease to hold: | |
+------------------------------------------+------------------------+
| 12. Date on which proxy holder will | N/A |
| cease to hold voting rights: | |
+------------------------------------------+------------------------+
+----------------------------+--------------------------------------+
| 13. Additional | Notification using the Total Voting |
| information: | Rights figure of 31,536,697 |
+----------------------------+--------------------------------------+
| 14. Contact name: | Matthew Wilson |
+----------------------------+--------------------------------------+
| 15. Contact telephone | 0113 235 7729 |
| number: | |
+----------------------------+--------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNSSRRVASAAR
Neuropharm (LSE:NPH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Neuropharm (LSE:NPH)
Historical Stock Chart
From Dec 2023 to Dec 2024
